Moody Aldrich Partners’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-46,731
| Closed | -$2.47M | – | 208 |
|
|
2024
Q3 | $2.47M | Sell |
46,731
-23,174
| -33% | -$1.22M | 0.45% | 86 |
|
|
2024
Q2 | $3.79M | Sell |
69,905
-2,992
| -4% | -$162K | 0.74% | 63 |
|
|
2024
Q1 | $5.11M | Buy |
72,897
+43,026
| +144% | +$3.02M | 0.87% | 43 |
|
|
2023
Q4 | $2.49M | Sell |
29,871
-64,577
| -68% | -$5.39M | 0.45% | 83 |
|
|
2023
Q3 | $2.78M | Buy |
94,448
+5,172
| +6% | +$152K | 0.53% | 72 |
|
|
2023
Q2 | $2.91M | Sell |
89,276
-270
| -0.3% | -$8.81K | 0.57% | 72 |
|
|
2023
Q1 | $3.15M | Sell |
89,546
-3,287
| -4% | -$116K | 0.64% | 68 |
|
|
2022
Q4 | $4.25M | Sell |
92,833
-2,257
| -2% | -$103K | 0.86% | 52 |
|
|
2022
Q3 | $4.61M | Sell |
95,090
-44,086
| -32% | -$2.14M | 0.95% | 44 |
|
|
2022
Q2 | $5.47M | Buy |
139,176
+44,620
| +47% | +$1.75M | 1.07% | 36 |
|
|
2022
Q1 | $3.48M | Buy |
94,556
+10,007
| +12% | +$368K | 0.49% | 72 |
|
|
2021
Q4 | $3.85M | Sell |
84,549
-15,631
| -16% | -$713K | 0.54% | 73 |
|
|
2021
Q3 | $3.58M | Buy |
+100,180
| New | +$3.58M | 0.45% | 80 |
|